BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 2009; 15(28): 3516-3522 [PMID: 19630107 DOI: 10.3748/wjg.15.3516] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Konstantynowicz J, Lebensztejn DM, Skiba E, Sobaniec-lotowska ME, Abramowicz P, Piotrowska-jastrzebska J, Kaczmarski M. Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children. J Bone Miner Metab 2011;29:315-20. [DOI: 10.1007/s00774-010-0219-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Chen J, Katz LH, Muñoz NM, Gu S, Shin JH, Jogunoori WS, Lee MH, Belkin MD, Kim SB, White JC, Andricovich J, Tzatsos A, Li S, Kim SS, Shetty K, Mishra B, Rashid A, Lee JS, Mishra L. Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation. Sci Rep 2016;6:30217. [PMID: 27456065 DOI: 10.1038/srep30217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
3 De A, Ray D, Lamoria S, Sharma V, Khurana TR. Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indian patients with cirrhosis. JGH Open 2020;4:945-9. [PMID: 33102768 DOI: 10.1002/jgh3.12369] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ansemant T, Mahy S, Piroth C, Ornetti P, Ewing S, Guilland JC, Croisier D, Duvillard L, Chavanet P, Maillefert JF, Piroth L. Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. BMC Infect Dis 2013;13:7. [PMID: 23295013 DOI: 10.1186/1471-2334-13-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
5 Thakur P, Cherian KE, Kapoor N, Rebekah G, Goel A, Zachariah U, Eapen CE, Thomas N, Paul TV. Proximal Hip Geometry, Trabecular Bone Score, Bone Mineral Density and Bone Mineral Parameters in Patients With Cryptogenic and Hepatitis B Related Cirrhosis- A Study From the Indian Subcontinent. J Clin Densitom 2021:S1094-6950(21)00019-6. [PMID: 33789805 DOI: 10.1016/j.jocd.2021.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Patel N, Muñoz SJ. Bone disease in cirrhosis. Clin Liver Dis (Hoboken) 2015;6:96-9. [PMID: 31040999 DOI: 10.1002/cld.498] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
7 Wintermeyer E, Ihle C, Ehnert S, Stöckle U, Ochs G, de Zwart P, Flesch I, Bahrs C, Nussler AK. Crucial Role of Vitamin D in the Musculoskeletal System. Nutrients 2016;8:E319. [PMID: 27258303 DOI: 10.3390/nu8060319] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 14.5] [Reference Citation Analysis]
8 González-Reimers E, Alvisa-Negrín J, Santolaria-Fernández F, Ros-Vilamajó R, Martín-González MC, Hernández-Betancor I, García-Valdecasas-Campelo E, González-Díaz A. Prognosis of osteopenia in chronic alcoholics. Alcohol 2011;45:227-38. [PMID: 21051177 DOI: 10.1016/j.alcohol.2010.09.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
9 Choudhary NS, Tomar M, Chawla YK, Bhadada SK, Khandelwal N, Dhiman RK, Duseja A, Bhansali A. Hepatic osteodystrophy is common in patients with noncholestatic liver disease. Dig Dis Sci. 2011;56:3323-3327. [PMID: 21573732 DOI: 10.1007/s10620-011-1722-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
10 Saeki C, Takano K, Oikawa T, Aoki Y, Kanai T, Takakura K, Nakano M, Torisu Y, Sasaki N, Abo M, Matsuura T, Tsubota A, Saruta M. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC Musculoskelet Disord. 2019;20:615. [PMID: 31878909 DOI: 10.1186/s12891-019-2983-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
11 Olmos-Martínez JM, Hernández JL, Fábrega E, Olmos JM, Crespo J, González-Macías J. Bone mineral density and trabecular bone score in treatment-naïve patients with non-cirrhotic hepatitis C virus infection. Arch Osteoporos 2020;15:72. [PMID: 32399944 DOI: 10.1007/s11657-020-00752-1] [Reference Citation Analysis]
12 Culafić D, Djonic D, Culafic-vojinovic V, Ignjatovic S, Soldatovic I, Vasic J, Beck TJ, Djuric M. Evidence of degraded BMD and geometry at the proximal femora in male patients with alcoholic liver cirrhosis. Osteoporos Int 2015;26:253-9. [DOI: 10.1007/s00198-014-2849-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
13 Zhang Y, Gao X, Liu T, Gao P, Li H, Liu N, Gao L, Wan G, Zhang Y, Duan X. Association between osteoporosis and hepatitis B cirrhosis: a case-control study. Afr Health Sci 2020;20:1610-6. [PMID: 34394221 DOI: 10.4314/ahs.v20i4.13] [Reference Citation Analysis]
14 Karoli Y, Karoli R, Fatima J, Manhar M. Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease. J Clin Diagn Res 2016;10:OC31-4. [PMID: 27656483 DOI: 10.7860/JCDR/2016/21539.8367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Santangelo A, Testaì M, Mamazza G, Zuccaro C, Albani S, Pavano S, Cappello A, Sambataro D, Atteritano M, Maugeri D. The bone mass (BM) and chronic cardiac decompensation (CCD) in an elderly population. Arch Gerontol Geriatr 2011;53:51-4. [PMID: 20537414 DOI: 10.1016/j.archger.2010.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Bhavsar-Burke I, Jansson-Knodell CL, Gilmore AC, Crabb DW. Review article: the role of nutrition in alcohol-associated liver disease. Aliment Pharmacol Ther 2021;53:1268-76. [PMID: 33896017 DOI: 10.1111/apt.16380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Duan XF, Fan XL. Chronic liver disease and osteoporosis. Shijie Huaren Xiaohua Zazhi 2010; 18(27): 2841-2845 [DOI: 10.11569/wcjd.v18.i27.2841] [Reference Citation Analysis]
18 Abdel-Ghaffar TY, Behairy EB, Abd El-Shaheed A, Mahdy K, El-Batanony M, Hussein MH, Sira MM. Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases. Gastroenterol Res. 2010;3:262-271. [PMID: 27942306 DOI: 10.4021/gr246w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
19 Saeki C, Tsubota A. Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:899. [PMID: 34575048 DOI: 10.3390/life11090899] [Reference Citation Analysis]
20 Mittal M, Bhagwati S, Siddiqi MI, Chattopadhyay N. A critical assessment of the potential of pharmacological modulation of aldehyde dehydrogenases to treat the diseases of bone loss. Eur J Pharmacol 2020;886:173541. [PMID: 32896553 DOI: 10.1016/j.ejphar.2020.173541] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H. Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res 2018;48:893-904. [PMID: 29734510 DOI: 10.1111/hepr.13192] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
22 Aller R, Luis Perez Castrillon J, Antonio de Luis D, Conde R, Izaola O, González Sagrado M, Concepción Velasco M, Alvarez T, Pacheco D. Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. Annals of Hepatology 2011;10:50-5. [DOI: 10.1016/s1665-2681(19)31587-x] [Cited by in Crossref: 15] [Article Influence: 1.4] [Reference Citation Analysis]
23 Fiorino S, Conti F, Gramenzi A, Loggi E, Cursaro C, Di Donato R, Micco L, Gitto S, Cuppini A, Bernardi M, Andreone P. Vitamins in the treatment of chronic viral hepatitis. Br J Nutr 2011;105:982-9. [PMID: 21255469 DOI: 10.1017/S0007114510004629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Gaddini GW, Grant KA, Woodall A, Stull C, Maddalozzo GF, Zhang B, Turner RT, Iwaniec UT. Twelve months of voluntary heavy alcohol consumption in male rhesus macaques suppresses intracortical bone remodeling. Bone 2015;71:227-36. [PMID: 25451322 DOI: 10.1016/j.bone.2014.10.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mora S, Giacomet V, Viganò A, Maruca K, Capelli S, Nannini P, Zuccotti GV. Areal Bone Mineral Density in Pediatric Patients with Chronic Hepatitis B or Chronic Hepatitis C. Calcif Tissue Int 2014;95:218-21. [DOI: 10.1007/s00223-014-9884-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Jhajharia A, Soni A, Pokharna R, Ashdhir P, Sharma SS, Nepalia S. Spectrum of chronic liver disease admitted to a medical college hospital in northern India: is there cause for concern? Indian J Gastroenterol 2014;33:480-1. [PMID: 24863622 DOI: 10.1007/s12664-014-0465-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 González-pérez JM, González-reimers E, Durán-castellón MDC, Santolaria-fernández F, Galindo-martín L, Rosvilamajó R, de la Vega-prieto MJ, Viña-rodríguez J, Abreu-gonzález P. Relative and combined effects of selenium, protein deficiency and ethanol on bone. Journal of Trace Elements in Medicine and Biology 2011;25:113-7. [DOI: 10.1016/j.jtemb.2011.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Vatsalya V, Kong M, Cave MC, Liu N, Schwandt ML, George DT, Ramchandani VA, McClain CJ. Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients. J Nutr Biochem. 2018;59:49-55. [PMID: 29960116 DOI: 10.1016/j.jnutbio.2018.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
29 Nussler AK, Wildemann B, Freude T, Litzka C, Soldo P, Friess H, Hammad S, Hengstler JG, Braun KF, Trak-Smayra V, Godoy P, Ehnert S. Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis. Arch Toxicol 2014;88:997-1006. [PMID: 24381012 DOI: 10.1007/s00204-013-1191-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
30 Lawson-Ayayi S, Cazanave C, Kpozehouen A, Barthe N, Mehsen N, Hessamfar M, Dupon M, Dabis F, Neau D; Groupe Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 Aquitaine Cohort. J Acquir Immune Defic Syndr 2013;62:430-5. [PMID: 23296138 DOI: 10.1097/QAI.0b013e3182845d88] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
31 Ghosh K, Shetty S. Bone health in persons with haemophilia: a review. Eur J Haematol 2012;89:95-102. [PMID: 22587752 DOI: 10.1111/j.1600-0609.2012.01803.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
32 Kim J, Kim SW, Lee SY, Kim TH, Jung JH. Bone mineral density in osteoporotic patients with pyogenic vertebral osteomyelitis: effect of early versus late treatment for osteoporosis. Osteoporos Int 2018;29:2761-70. [PMID: 30225674 DOI: 10.1007/s00198-018-4695-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Ranjan R, Rampal S, Jaiman A, Tokgöz MA, Koong JK, Ramayah K, Rajaram R. Common musculoskeletal disorders in chronic liver disease patients. Jt Dis Relat Surg 2021;32:818-23. [PMID: 34842121 DOI: 10.52312/jdrs.2021.25] [Reference Citation Analysis]
34 Liu Z, Han T, Werner H, Rosen CJ, Schaffler MB, Yakar S. Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass. J Bone Miner Res 2018;33:123-36. [PMID: 28902430 DOI: 10.1002/jbmr.3290] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
35 Gutierrez JA, Parikh N, Branch AD. Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis. 2011;31:387-398. [PMID: 22189978 DOI: 10.1055/s-0031-1297927] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
36 Higa GM, Hicks J, Isabella C. Adjudication of the alleged role of vitamin d in the antimicrobial pathway. Scientifica (Cairo) 2012;2012:129516. [PMID: 24278668 DOI: 10.6064/2012/129516] [Reference Citation Analysis]
37 Mikosch P. Alcohol and bone. Wien Med Wochenschr 2014;164:15-24. [PMID: 24477631 DOI: 10.1007/s10354-013-0258-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
38 Lai JC, Shoback DM, Zipperstein J, Lizaola B, Tseng S, Terrault NA. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C. Dig Dis Sci 2015;60:1813-9. [PMID: 25563723 DOI: 10.1007/s10620-014-3507-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
39 Ionele CM, Turcu-stiolica A, Subtirelu MS, Ungureanu BS, Cioroianu GO, Rogoveanu I. A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis. JCM 2022;11:3807. [DOI: 10.3390/jcm11133807] [Reference Citation Analysis]
40 Veidal SS, Vassiliadis E, Bay-Jensen AC, Tougas G, Vainer B, Karsdal MA. Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats. Fibrogenesis Tissue Repair. 2010;3:5. [PMID: 20359335 DOI: 10.1186/1755-1536-3-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
41 Goubraim R, Kabbaj N, Salihoun M, Chaoui Z, Nya M, Amrani N. Metabolic Bone Disease in Viral Cirrhosis: A Prospective Study. ISRN Hepatol 2013;2013:276563. [PMID: 27398385 DOI: 10.1155/2013/276563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Cholongitas E, Theocharidou E, Goulis J, Tsochatzis E, Akriviadis E, Burroughs K. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection. Aliment Pharmacol Ther. 2012;35:634-646. [PMID: 22316435 DOI: 10.1111/j.1365-2036.2012.05000.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
43 Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol. 2011;54:887-893. [PMID: 21145801 DOI: 10.1016/j.jhep.2010.08.036] [Cited by in Crossref: 169] [Cited by in F6Publishing: 173] [Article Influence: 15.4] [Reference Citation Analysis]
44 Ahmed HM, El-shereef HK, El-gendi SS, El-sherif WT, Bakheet MY, Galal GM, Abdel-wahab SH, El-moneum OA. Leptin, osteocalcin, and bone mineral density in post-hepatitic liver cirrhosis. Arab Journal of Gastroenterology 2010;11:130-5. [DOI: 10.1016/j.ajg.2010.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Orrskog S, Medin E, Tsolova S, Semenza JC. Causal inference regarding infectious aetiology of chronic conditions: a systematic review. PLoS One 2013;8:e68861. [PMID: 23935899 DOI: 10.1371/journal.pone.0068861] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
46 Gerova DI, Galunska BT, Ivanova II, Kotzev IA, Tchervenkov TG, Balev SP, Svinarov DA. Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic hepatitis C viral infection. Scand J Clin Lab Invest. 2014;74:665-672. [PMID: 25005344 DOI: 10.3109/00365513.2014.930710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
47 Pirgon O, Bilgin H, Tolu I, Odabas D. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2011;75:189-195. [PMID: 21521307 DOI: 10.1111/j.1365-2265.2011.04038.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
48 Chinnaratha MA, Chaudhary S, Doogue M, McCormick RJ, Woodman RJ, Wigg AJ. Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis. Intern Med J 2015;45:1230-5. [PMID: 26247615 DOI: 10.1111/imj.12866] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
49 Malham M, Peter Jørgensen S, Lauridsen AL, Ott P, Glerup H, Dahlerup JF. The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D2) or cholecalciferol (D2) in alcoholic liver cirrhosis. Eur J Gastroenterol Hepatol. 2012;24:172-178. [PMID: 22027703 DOI: 10.1097/MEG.0b013e32834d1755] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
50 Huang WH, Yu MC, Huang JY, Lai PC. Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients. PLoS One. 2013;8:e63263. [PMID: 23675468 DOI: 10.1371/journal.pone.0063263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
51 Jeong BC, Oh SH, Lee MN, Koh JT. Macrophage-Stimulating Protein Enhances Osteoblastic Differentiation via the Recepteur d'Origine Nantais Receptor and Extracellular Signal-Regulated Kinase Signaling Pathway. J Bone Metab 2020;27:267-79. [PMID: 33317230 DOI: 10.11005/jbm.2020.27.4.267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Abo M, Saruta M, Tsubota A. Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease. J Clin Med 2020;9:E2381. [PMID: 32722566 DOI: 10.3390/jcm9082381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
53 Eltayeb AA, Abdou MAA, Abdel-aal AM, Othman MH. Vitamin D status and viral response to therapy in hepatitis C infected children. World J Gastroenterol 2015; 21(4): 1284-1291 [PMID: 25632203 DOI: 10.3748/wjg.v21.i4.1284] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
54 Styskel B, Natarajan Y, Kanwal F. Nutrition in Alcoholic Liver Disease. Clinics in Liver Disease 2019;23:99-114. [DOI: 10.1016/j.cld.2018.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
55 Bukhari T, Jafri L, Majid H, Khan AHH, Siddiqui I. Determining Bone Turnover Status in Patients With Chronic Liver Disease. Cureus 2021;13:e14479. [PMID: 33996337 DOI: 10.7759/cureus.14479] [Reference Citation Analysis]
56 Walker Harris V, Sutcliffe CG, Araujo AB, Chiu GR, Travison TG, Mehta S, Sulkowski MS, Higgins Y, Thomas DL, Dobs AS, Beck TJ, Brown TT. Hip bone geometry in HIV/HCV-co-infected men and healthy controls. Osteoporos Int 2012;23:1779-87. [PMID: 21901477 DOI: 10.1007/s00198-011-1769-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
57 Tirosh-Levy S, Perl S, Valentine BA, Kelmer G. Erythrocytosis and fatigue fractures associated with hepatoblastoma in a 3-year-old gelding. J S Afr Vet Assoc 2019;90:e1-5. [PMID: 31038324 DOI: 10.4102/jsava.v90i0.1708] [Reference Citation Analysis]
58 Rabenda V, Nicolet D, Beaudart C, Bruyère O, Reginster JY. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int 2013;24:121-37. [PMID: 22638709 DOI: 10.1007/s00198-012-2015-9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
59 El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol 2011;55:770-6. [PMID: 21338640 DOI: 10.1016/j.jhep.2011.01.035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
60 Kong J, Ding Y, Zhang C, Fu Y, Du J, Lu C, Dou X, Chen Y, Li YC, Zhao Q. Severe vitamin D-deficiency and increased bone turnover in patients with hepatitis B from northeastern China. Endocr Res 2013;38:215-22. [PMID: 24073717 DOI: 10.3109/07435800.2013.768266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
61 Yadav A, Carey EJ. Osteoporosis in chronic liver disease. Nutr Clin Pract. 2013;28:52-64. [PMID: 23263929 DOI: 10.1177/0884533612470145] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
62 Santos LA, Romeiro FG. Diagnosis and Management of Cirrhosis-Related Osteoporosis. Biomed Res Int. 2016;2016:1423462. [PMID: 27840821 DOI: 10.1155/2016/1423462] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
63 Peruzzi B, Teti A. The Physiology and Pathophysiology of the Osteoclast. Clinic Rev Bone Miner Metab 2012;10:71-97. [DOI: 10.1007/s12018-011-9086-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
64 López-Larramona G, Lucendo AJ, González-Castillo S, Tenias JM. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol 2011; 3(12): 300-307 [PMID: 22216370 DOI: 10.4254/wjh.v3.i12.300] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
65 González-Pérez JM, González-Reimers E, DeLaVega-Prieto MJ, Durán-Castellón Mdel C, Viña-Rodríguez J, Galindo-Martín L, Alvisa-Negrín J, Santolaria-Fernández F. Relative and combined effects of ethanol and protein deficiency on bone manganese and copper. Biol Trace Elem Res 2012;147:226-32. [PMID: 22190260 DOI: 10.1007/s12011-011-9296-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
66 Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, Esteghamati A, Abdollahi A, Mazloumi M. Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int. 2010;4:634-640. [PMID: 21063488 DOI: 10.1007/s12072-010-9194-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
67 Kaya M, Işık D, Beştaş R, Evliyaoğlu O, Akpolat V, Büyükbayram H, Kaplan MA. Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol 2013; 5(11): 627-634 [PMID: 24303091 DOI: 10.4254/wjh.v5.i11.627] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
68 Bansal RK, Kumar M, Sachdeva PR, Kumar A. Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation. United European Gastroenterol J 2016;4:77-83. [PMID: 26966526 DOI: 10.1177/2050640615584535] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
69 Bonefeld K, Møller S. Insulin-like growth factor-I and the liver. Liver Int. 2011;31:911-919. [PMID: 21733081 DOI: 10.1111/j.1478-3231.2010.02428.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
70 Ehnert S, Aspera-Werz RH, Ruoß M, Dooley S, Hengstler JG, Nadalin S, Relja B, Badke A, Nussler AK. Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. Int J Mol Sci 2019;20:E2555. [PMID: 31137669 DOI: 10.3390/ijms20102555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]